Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2011
03/23/2011CN1847236B 7,8-dihydroxy-2-oxo-2H-benzopyran derivative and its synthesis process and medicinal use
03/23/2011CN101990547A Il-23 receptor antagonists and uses thereof
03/23/2011CN101990541A Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
03/23/2011CN101987865A Antagonist of luteinizing hormone releasing hormone (LHRH) containing hydantoin structure
03/23/2011CN101987199A Antipyretic and analgesic injection composition
03/23/2011CN101987198A Medicinal composition
03/23/2011CN101987189A Detoxifying and channel dredging external application powder
03/23/2011CN101987148A Chinese herbal medicine prescription for treating facial neuritis and preparation method thereof
03/23/2011CN101987137A Traditional Chinese medicinal lotion formula for treating exogenous fever
03/23/2011CN101987123A Medicament for easing pain of human body and preparation method thereof
03/23/2011CN101987122A Medicament for easing pain of human body and preparation method thereof
03/23/2011CN101987118A Food therapy health care wine for treating rheumatoid diseases and rheumatism
03/23/2011CN101987114A Formulation of traditional Chinese medicinal herbal lotion for external use
03/23/2011CN101987095A Application of daphnetin to preparation of medicament for treating rheumatism, rheumatoid arthritis and sprain caused by falling
03/23/2011CN101987092A Novel pharmaceutical composition containing analgesic
03/23/2011CN101987088A Preparation and applications of paeonol controlled-release preparation
03/23/2011CN101987053A Natural mineral traditional Chinese medicinal hot pack
03/23/2011CN101716317B Orally taken and externally applied traditional Chinese medicine composite for treating rheumatoid arthritis
03/23/2011CN101698033B Big plaster for treating various rheumatic osteopathy and traumatic injuries
03/23/2011CN101664449B Separation method of rhubarb-combined anthraquinone and rhubarb tannin
03/23/2011CN101647906B Preparation containing henbane and daturaflower for treating cancer pain and surgery wound pain
03/23/2011CN101628029B Medicine with functions of relaxing muscles and tendons and promoting blood circulation
03/23/2011CN101601767B Traditional Chinese medicine lotion for treating calcanodynia
03/23/2011CN101584848B Chinese medicament for treating qi stagnation, food accumulation and cold bind type bellyache diseases
03/23/2011CN101450197B Traditional Chinese medicine for treating rheumatism, rheumatoid disease
03/23/2011CN101417057B Traditional Chinese medicine decoction for treating rheumatic heart disease
03/23/2011CN101401820B Injection novel medicine for treating systematic lupus erythematosus
03/23/2011CN101385843B Nano medicine magnet therapy plaster for relieving the swelling and easing pain
03/23/2011CN101274000B Medicine use of herb aralia elata seem
03/23/2011CN101181560B Medicine for treating tongluozhitong of rheumatoid arthritis
03/23/2011CN101175753B Compounds and compositions as protein kinase inhibitors
03/23/2011CN101175751B Crystal of indole derivative having piperidine ring and process for production thereof
03/23/2011CN101168041B Rheumatism treating medicine
03/23/2011CN101112417B Rheum defervescence liniment and method for preparing the same
03/22/2011US7910741 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
03/22/2011US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders
03/22/2011US7910617 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound
03/22/2011US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
03/22/2011US7910099 Antibodies to VLA-1
03/22/2011US7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
03/22/2011CA2615856C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
03/22/2011CA2492342C Novel bio-active pyrimidine derivatives
03/22/2011CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/22/2011CA2487238C Hydroxy tetrahydro-naphthalenylurea derivatives
03/22/2011CA2480273C Ph-sensitive polymer
03/22/2011CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
03/22/2011CA2471538C Pyrrolopyrimidines
03/22/2011CA2464067C Method for treating non-neuropathic pain
03/22/2011CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof
03/22/2011CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group
03/22/2011CA2432572C Oxybenzamides derivatives as factor xa inhibitors
03/22/2011CA2396519C A process for isolation of osteopontin from milk
03/22/2011CA2359334C Bifidobacterium in the treatment of inflammatory disease
03/22/2011CA2240409C Mammalian cx3c chemokine genes
03/17/2011WO2011032169A2 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
03/17/2011WO2011031695A1 High affinity human antibodies to human protease-activated receptor-2
03/17/2011WO2011031602A1 Nutritional compositions for modulating inflammation including exogenous vitamin k2
03/17/2011WO2011031601A2 Nutritional compositions including exogenous vitamin k2
03/17/2011WO2011031476A2 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
03/17/2011WO2011031237A1 Phytochemical compositions including sesamin for anti¬ inflammatory, anti-cytokine storm, and other uses
03/17/2011WO2011031236A1 Phytochemical compositions including xanthones for anti-inflammatory, anti-cytokine storm, and other uses
03/17/2011WO2011030798A1 8-oxodihydropurine derivative
03/17/2011WO2011030205A1 N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation
03/17/2011WO2011029804A1 Inhibitors of jak
03/17/2011WO2010131909A3 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
03/17/2011WO2010110631A3 Benzopyran derivatives, pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition for preventing or treating inflammatory diseases containing same as an active ingredient
03/17/2011US20110066101 Non-invasive ocular drug delivery
03/17/2011US20110065918 New phenylalanine derivatives
03/17/2011US20110065800 Formulations for cathepsin k inhibitors
03/17/2011US20110065793 Highly purified ethyl epa and other epa derivatives
03/17/2011US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
03/17/2011US20110065772 Treatment of rheumatoid arthritis
03/17/2011US20110065771 Inflammatory bowel disease therapies
03/17/2011US20110065770 Formulations comprising antisense nucleotides to connexins
03/17/2011US20110065764 5- phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators
03/17/2011US20110065760 Compounds for the inhibition of rotamases and use thereof
03/17/2011US20110065750 Solid Forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and Methods of Making the Same
03/17/2011US20110065748 Compositions and methods for treating disorders of gastrointestinal motility
03/17/2011US20110065745 Polysubstituted 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof
03/17/2011US20110065738 Polycyclic guanine derivatives and use thereof
03/17/2011US20110065736 Quinazoline derivatives as vegf inhibitors
03/17/2011US20110065727 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/17/2011US20110065716 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/17/2011US20110065712 Tricyclic compounds and pharmaceutical uses thereof
03/17/2011US20110065711 Substituted triazolo-pyridazine derivatives
03/17/2011US20110065704 Compounds for modulating rna binding proteins and uses therefor
03/17/2011US20110065701 Pharmaceutical compounds
03/17/2011US20110065700 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/17/2011US20110065699 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/17/2011US20110065698 Novel protein kinase modulators
03/17/2011US20110065688 Therapeutic piperazines
03/17/2011US20110065685 Novel indoles are cannabinoid receptor ligands
03/17/2011US20110065683 Trisubstituted pyrazoles as acetylcholine receptor modulators
03/17/2011US20110065681 Amide compounds, compositions and uses thereof
03/17/2011US20110065679 Substituted Porphyrins
03/17/2011US20110065678 Isoxazolidine derivatives
03/17/2011US20110065677 Methods of Treating Inflammation with Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastrointestinal Tract and Providing Enhanced Therapeutic Activity
03/17/2011US20110065675 Azo dye related small molecule modulators of protein-protein interactions
03/17/2011US20110065649 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
03/17/2011US20110065648 Advantageous mu-opiate receptor peptide compounds